Table 2: Intrasession repeatability assessment of ocular blood flow metrics.
Intrasession CV (%) |
Ocular Blood Flow Metrics | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ROI | Subjects | Dip | Mean | Peak | VRI | VFI | TtR | TtF | Skew | ATI | BOT |
Optic Disc | Healthy Controls | 2.3 ± 0.9* | 1.8 ± 0.7* | 2.0 ± 0.9 | 8.0 ± 2.9 | 4.5 ± 1.7* | 6.6 ± 2.5 | 3.7 ± 1.3* | 10.2 ± 5.8 | 6.0 ± 2.2 | 3.8 ± 2.1* |
Glaucoma Suspect | 3.3 ± 1.5* | 2.2 ± 0.9* | 2.2 ± 0.9 | 7.6 ± 2.4 | 4.3 ± 1.4* | 6.6 ± 2.4 | 4.2 ± 1.3* | 10.6 ± 3.2 | 6.0 ± 2.0 | 4.8 ± 1.6* | |
Glaucoma | 4.6 ± 2.7* | 2.7 ± 0.9* | 2.6 ± 1.2 | 8.6 ± 2.7 | 7.4 ± 4.9* | 7.6 ± 2.6 | 7.0 ± 6.3* | 15.5 ± 9.0 | 9.0 ± 5.7 | 6.4 ± 3.3* | |
Disc Vessel | Healthy Controls | 2.2 ± 0.8* | 1.6 ± 0.7* | 1.8 ± 0.8 | 7.9 ± 2.8 | 4.4 ± 1.6* | 6.6 ± 2.5 | 3.7 ± 1.3* | 13.3 ± 10 | 6.0 ± 2.2 | 4.6 ± 3.0 |
Glaucoma Suspect | 3.5 ± 1.7* | 2.2 ± 1.0* | 2.0 ± 1.1 | 7.5 ± 2.4 | 4.3 ± 1.5* | 6.6 ± 2.4 | 4.2 ± 1.3* | 15.7 ± 8.3 | 6.0 ± 2.0 | 6.4 ± 3.0 | |
Glaucoma | 4.6 ± 2.8* | 2.6 ± 1.0* | 2.5 ± 1.1 | 8.7 ± 2.7 | 7.4 ± 5.1* | 7.6 ± 2.6 | 7.0 ± 6.3* | 17.9 ± 11.7 | 9.0 ± 5.7 | 7.6 ± 3.7 | |
Disc Perfusion | Healthy Controls | 2.9 ± 1.0* | 2.2 ± 0.8* | 2.5 ± 1.0 | 8.3 ± 3.0 | 4.7 ± 1.7* | 6.6 ± 2.5 | 3.7 ± 1.3* | 10.1 ± 5.7 | 6.0 ± 2.2 | 3.8 ± 2.1* |
Glaucoma Suspect | 4.2 ± 1.6* | 2.7 ± 0.8* | 2.8 ± 0.9 | 7.9 ± 2.9 | 4.6 ± 1.3* | 6.6 ± 2.4 | 4.2 ± 1.3* | 10.8 ± 4.7 | 6.0 ± 2.0 | 5.2 ± 1.8* | |
Glaucoma | 5.3 ± 2.8* | 3.0 ± 0.9* | 2.9 ± 1.3 | 8.9 ± 3.0 | 7.3 ± 4.7* | 7.6 ± 2.6 | 7.0 ± 6.3* | 13.8 ± 7.5 | 9.0 ± 5.7 | 6.5 ± 3.1* | |
Fovea | Healthy Controls | 2.2 ± 0.8 | 1.6 ± 0.6 | 1.7 ± 0.7* | 8.4 ± 3.3 | 5.0 ± 2.4 | 7.3 ± 3.2 | 4.3 ± 2.2 | 13.3 ± 7.0 | 7.3 ± 3.4 | 4.1 ± 1.5* |
Glaucoma Suspect | 2.5 ± 1.4 | 1.9 ± 0.7 | 2.3 ± 0.8* | 8.4 ± 2.1 | 5.5 ± 2.5 | 7.2 ± 2.0 | 5.1 ± 3.1 | 20.4 ± 11.5 | 7.0 ± 2.0 | 7.9 ± 3.4* | |
Glaucoma | 3.4 ± 2.6 | 2.3 ± 1.0 | 2.9 ± 1.3* | 9.0 ± 4.2 | 6.7 ± 6.9 | 6.4 ± 3.5 | 5.9 ± 7.7 | 13.1 ± 7.4 | 7.7 ± 3.8 | 7.4 ± 2.5* |